BioInfra Life Science Inc. Logo

BioInfra Life Science Inc.

Develops multi-biomarker blood tests for early cancer screening and gene treatments.

266470 | KO

Overview

Corporate Details

ISIN(s):
KR7266470004
LEI:
Country:
South Korea
Address:
서울특별시 금천구 가산로9길 66 제1동 712호(가산동, 더리즌밸리지식산업센터), 서울특별시

Description

BioInfra Life Science Inc. is a biotechnology company focused on cancer prevention, early detection, and treatment. The company's core technology is a multi-biomarker blood test, an in-vitro diagnostic solution designed for the early screening of eight major cancers, including lung, liver, stomach, colorectal, prostate, breast, pancreatic, and ovarian cancer. This test analyzes cancer risk from a small blood sample. In addition to its diagnostic platform, the company develops cancer gene treatments and technologies to monitor the potential for metastasis and recurrence, aiming to provide innovative solutions in the healthcare field.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2024-12-06 00:00
기업설명회(IR)개최결과
Korean 6.7 KB
2024-12-03 00:00
불성실공시법인지정예고 (공시불이행)
Korean 4.5 KB
2024-11-26 00:00
[기재정정]주요사항보고서(유상증자결정)
Korean 43.2 KB
2024-11-22 00:00
타법인주식및출자증권취득결정
Korean 24.0 KB
2024-11-20 00:00
주요사항보고서(유상증자결정)
Korean 33.3 KB
2024-10-22 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 22.3 KB
2024-10-22 00:00
주식등의대량보유상황보고서(일반)
Korean 72.9 KB
2024-10-21 00:00
증권발행결과(자율공시)
Korean 5.3 KB
2024-09-30 00:00
전환사채(해외전환사채포함)발행후만기전사채취득 (제1회차)
Korean 8.4 KB
2024-09-19 00:00
본점소재지변경
Korean 5.0 KB
2024-09-19 00:00
[기재정정]주요사항보고서(유상증자결정)
Korean 30.3 KB
2024-09-09 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 53.3 KB
2024-09-09 00:00
주식등의대량보유상황보고서(일반)
Korean 132.5 KB
2024-09-04 00:00
주식등의대량보유상황보고서(일반)
Korean 80.5 KB
2024-09-02 00:00
최대주주변경
Korean 15.3 KB

Automate Your Workflow. Get a real-time feed of all BioInfra Life Science Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for BioInfra Life Science Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for BioInfra Life Science Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

1NKEMIA Logo
Biotechnology company providing R&D and services for the life sciences sector.
Spain
IKM
2cureX AB Logo
Develops an IVD test using 3D tumoroids to predict patient response to cancer drugs.
Sweden
2CUREX
Abera Bioscience AB Logo
Develops mucosal vaccines using a proprietary Outer Membrane Vesicle (OMV) platform.
Sweden
ABERA
Clinical-stage biopharma developing therapeutics for oncology and viral diseases.
South Korea
203400
ABL Bio Inc. Logo
Develops bispecific antibody therapeutics for oncology and neurodegenerative diseases.
South Korea
298380
Abpro Holdings, Inc. Logo
Clinical-stage biotech developing antibody therapeutics for oncology and ophthalmology.
United States of America
ABP
Absci Corp Logo
A generative AI drug creation company developing biologic medicines.
United States of America
ABSI
Achiko AG Logo
A digital services platform for cross-border business compliance and engagement.
Switzerland
ACHI
Active Biotech Logo
Biotechnology company developing drugs for oncology and inflammatory eye disorders.
Sweden
ACTI
Adagene Inc. Logo
Clinical-stage biotech developing antibody-based immunotherapies for oncology.
United States of America
ADAG

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.